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Conclusion: Regarding the CTO intervention outcomes following PCI with DESs,
there was no significant difference between diabetics and non-diabetics in procedure
related complications and one year cumulative clinical outcomes.
TCT-434
Impact of Chronic Dialysis on Below the Knee Intervention Outcomes in
Patients with Critical Limb Ischemia
Amro Elnagar, Seung Woon Rha, Byoung Geol Choi, Sung Il Im, SunWon Kim, Jin
Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju
Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh
Korea University Guro Hospital, Seoul, Republic of Korea
Background: Chronic dialysis patients (pts) are at an increased risk of peripheral artery
disease. Outcome of below the knee (BTK) intervention in dialysis patients remains
poorly understood. The aim of this study is to clarify the BTK intervention outcomes
in dialysis pts as compared with those without on dialysis.
Methods: A total 82 consecutive patients who underwent BTK intervention were
enrolled for the study. Study population was divided into 2 groups; Control group-no
dialysis (n= 68 pts, 105 lesions) and Dialysis group-peritoneal or hemodialysis (n=14
pts, 34 lesions). Procedural and major clinical outcomes up to 1 year were compared
between the two groups.
Results: Baseline clinical, procedural and angiographic characteristics were similar
between the two groups. Post procedural ischemic complications and major clinical
outcomes including mortality and repeat PTA were similar between the two groups up
to 1 year. However, the incidence of surgical intervention for wound management
including ostectomy & amputation were significant higher in the dialysis group. (Table)
Conclusion: In this study, despite of similar major angiographic and clinical outcomes
following successful BTK intervention in dialysis pts, they had significant higher rate
of surgical intervention including ostectomy and amputation up to one year, suggesting
special care with intensive medical management should be recommend.
TCT-435
Long-Term (5-Year) Outcomes Of Drug-Eluting Stents and Coronary-Artery
Bypass Grafting for Multivessel Coronary Revascularization In Diabetic and
Nondiabetic Patients
Yong-Giun Kim, Duk-Woo Park, Gyung-Min Park, Ki Won Hwang, Woo Seok Lee,
Hae-Geun Song, Jung-Min Ahn, Won-Jang Kim, Jong-Young Lee, Soo-Jin Kang,
Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung
Park
Asan Medical Center, Seoul, Republic of Korea
Background: Diabetes mellitus is a major risk factor for coronary artery disease
(CAD) and prone to a diffuse, multivessel and rapidly progressive form. Optimal
revascularization treatment in diabetic and nondiabetic patients with multivessel CAD
remains in dispute.
Methods: We evaluated 3,042 patients with multivessel disease who received DES
(n=1,547) or underwent CABG (n=1,495) between January 2003 and December 2005
and for whom complete follow-up data were available for median 5.6 years. We
compared the effects of DES and CABG on adverse outcomes (death; a composite
outcome of death, myocardial infarction [MI], or stroke; and repeat revascularization),
according to diabetic status.
Results: In diabetic patients, after adjustment for differences in baseline risk factors,
5-year risk of death (hazard ratio [HR]: 1.12; 95% confidence interval [CI], 0.72 to
2.09; P=0.61) and composite of death, MI, or stroke (HR: 1.23; 95% CI, 0.81 to 1.85;
P=0.34) were similar between the DES and CABG group. However, the rate of repeat
revascularization was significantly higher in the DES group than in the CABG group
(HR: 3.28; 95% CI, 1.94 to 5.54; P<0.001). These trends were consistent in nondiabetic
patients (HR: 0.86; 95% CI, 0.61 to 1.12; P=0.40 for death, HR: 0.81; 95% CI, 0.61 to
1.09; P=0.17 for composite of death, MI, or stroke, HR: 2.80; 95% CI, 2.00 to 3.92;
P<0.001 for repeat revascularization). In addition, we did not observe significant
interaction between treatment outcomes and diabetic status (Pinteraction = 0.22 for
death, Pinteraction = 0.13 for composite of death, MI, or stroke, Pinteraction = 0.46
for repeat revascularization).
Conclusion: For multivessel CAD patients receiving percutaneous or surgical
revascularization, there was no significant difference of treatment effect according to
diabetic status.
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Background: We performed a patient level meta-analysis of 9-month clinical outcome
in diabetic versus non-diabetic patients with coronary bifurcation lesions treated by
drug eluting stents based on the British Bifurcation Coronary Old New and Evolving
strategies study (BBC ONE), the Nordic Bifurcation Study, the Nordic Bifurcation
Stent Technique Study and the Nordic-Baltic Bifurcation study III on final kissing
balloon dilatation.
Methods: Nine-month clinical follow-up were available for a total of 1816 patients
including 249 diabetic patients. MACE results were analyzed by propensity score
adjusted Cox regression.
Results: The mean age was 65±9 years in the diabetes group and 63±10 years in non-
diabetes group. In the diabetes and non-diabetes groups, 24% and 28% were females,
mean main vessel reference diameters were 3.3 mm vs. 3.2 mm, and side branch
reference diameters were 2.6 mm vs. 2.5 mm, respectively. True bifurcation lesions
were treated in 63 % vs. 66 % and complex stenting techniques were performed in
45% in 49% of cases in diabetic and non-diabetic patients. Major Adverse Cardiac
Events (MACE) rate was 8.8% in diabetic patients vs. 7.5% in non-diabetic patients
(HR 1.2 [95% CI 0.7 to 1.8], p= 0.48). MACE was a composite endpoint of total death
(1.6 vs 1.0%, p=0.42), non procedure-related myocardial infarction (1.6% vs. 2.2%,
p=0.59) and target vessel revascularization (7.6% vs. 6.2%, p=0.38). Procedure-related
myocardial infarction occurred in 9.6% of diabetic patients vs. 6.3% in non-diabetic
patients (p=0.049).
Conclusion: Diabetes was not associated with increased 9-month MACE in patients
treated for bifurcation lesions with drug eluting stents in BBC ONE and the Nordic
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Bifurcation Studies. Procedure-related myocardial infarction was more frequent in
diabetic patients.
Heart Disease in the Elderly 
(Abstract nos 407 - 415)
TCT-407
Population-based Analysis of the Epidemiology and Reintervention Rates of
Cardiovascular Stenting Procedures: A Medicare Study
Jasmine D Patel1, 2, Kevin L Ong1, 2, Heather N Watson1, Carrie M Kuehn1, Jorge A
Ochoa1
1Exponent, Philadelphia, PA; 2Drexel University, Philadelphia, PA
Background: Coronary artery disease (CAD) leads to a continuous narrowing of the
arteries which can result in ischemia and possible myocardial infarction. It is now
common practice to use coronary stents following PTCA to restore blood flow in
patients with CAD. With advances in technology and development of the drug-eluting
stent, the utilization of these devices has changed dramatically. The purpose of this
study is to evaluate the utilization of bare-metal stents (BMS) and drug-eluting stents
(DES) and their reintervention rates in the U.S. from 1997-2009.
Methods: The Medicare 5% LDS analytical files were queried to identify patients with
BMS and DES between 1997-2009 using ICD-9-CM. The prevalence of these
procedures was calculated as a function of age, gender, race and geographic region.
The reintervention rate, average length of stay, and hospitalization charges were also
assessed.
Results: A total of 88,000 BMS procedures were identified between 1997-2009 with
a reintervention rate of 31%. In addition, 68,300 DES procedures were identified from
2002-2009 with an overall reintervention rate of 19%. The majority of DES and BMS
were implanted in white (89-90%), male (58-59%) patients between the ages of 65 and
84 (78-80%). A large number of these procedures were conducted in the south (41%)
and midwest regions (27-29%) of the United States. The reintervention rate due to
infection/inflammation was 0.7% and 0.4% in patients with BMS and DES,
respectively. Over 35% of these patients undergoing repeat procedures stayed in the
hospital ≥ 5 days. Furthermore, the prevalence of hypertension, atrial fibrillation, and
cardiomyopathy was higher in the reintervention patient population when compared
to patients undergoing primary stenting procedures. The average hospitalization
charges for primary DES procedures was $64,000, whereas the average charge for
reintervention due to infection/inflammation was $82,000. The average charges for
BMS procedures were $10,000-$23,000 lower than DES procedures.
Conclusion: The patient demographics for DES and BMS utilization were similar
across race, gender, age and geographic region. However, a reduction in the overall
reintervention rates was observed in patients with a DES. Further analysis of mortality
and thrombosis risk may provide a mechanism to evaluate the comparative safety and
effectiveness of these procedures.
TCT-408
Effect of invasive strategy on long-term outcome in elderly Chinese patients
with non-ST-elevation myocardial infarction
Shao-Sung Huang, Ying-Hwa Chen, Jaw-Wen Chen, Shing-Jong Lin
Taipei Veterans General Hospital, Taipei, Taiwan
Background: The benefit of invasive strategy in elderly Asian ethnic populations with
non-ST-elevation myocardial infarction (NSTEMI) remains unclear. The aim of this
study was to determine the effect of in-hospital revascularization on long-term
prognosis in elderly Chinese patients with NSTEMI, comparison with younger patients.
Methods: A total of 343 consecutive NSTEMI patients (148 over the age of 75 years
and 195 aged < 75 years) were enrolled. All patients were followed up for at least 3
years or until the occurrence of a major event. The primary end point was all-cause
mortality. The secondary end point was the combined occurrence of major adverse
cardiovascular events (MACE), including death, nonfatal MI, and ischemic stroke.
Results: Angiography was performed less frequently in elderly patients (66% vs. 76%;
P = 0.027). Extent of coronary artery disease was greater in elderly than in younger
patients. Multiple logistic regression analysis confirmed the benefit of in-hospital
revascularization on the 3-year mortality in young [odds ratio (OR) 0.37, 95%
confidence interval (CI) 0.15-0.91] and elderly (OR 0.36, 95% CI 0.16-0.78) patients.
In-hospital revascularization was also associated with reductions in 3-year MACE (OR
0.38, 95% CI 0.17-0.83 in young; OR 0.43, 95% CI 0.21-0.91 in elderly).
Conclusion: In Asian ethnic patients with NSTEMI, angiography was less likely to
be undertaken with advancing patient age. Revascularization, however, when
performed, was associated with significant benefits at 1 year and 3 years, independent
of age, suggesting that advanced age alone should not be regarded as a contraindication
to invasive management following presentation with NSTEMI.
TCT-409
Long-Term Clinical Follow-Up Of Percutaneous Coronary Intervention In
Nonagenarians
Paolo Angioli, Simone Grotti, Francesco Liistro, Kenneth Ducci, Giovanni Falsini,
Leonardo Bolognese
Cardiovascular, San Donato Hospital, Arezzo, Italy
Background: Age is an important predictor of mortality in patients undergoing
percutaneous coronary intervention (PCI). The aim of this study is to report the data
of safety and efficacy of PCI in nonagenarians with acute coronary syndrome (ACS)
on long-term clinical outcome.
Methods: We performed a retrospective analysis on all consecutive nonagenarians
(aged >89 years) patients admitted in our Institution for ACS, from May 2002 to
January 2011, and treated with PCI.
Results: 90 nonagenarians (mean age 91.2 years) (male sex 38%) represent the study
population. Diabetes mellitus was present in 21% of patients, ST-elevation acute
myocardial infarction (STEMI) in 59% and 15.6% were in Killip class III or IV. The
mean follow-up was 2.4 years. In-hospital mortality was 17%. The 30-day mortality
rate was 20%. The cumulative survival rate for all nonagenarians at 1 year and 3 years
was 70% and 54% respectively. During the follow-up period, patients with Killip class
III-IV showed higher cardiac mortality rates compared with those with Killip I-II
(64.3% vs 13.2%, p<0.0001). Cox regression analysis showed Killip class III-IV as an
independent predictor of long-term cardiac death (OR 7.2, 95% CI 1.6-31.3, p=0.008).
Conclusion: PCI in nonagenarians ACS patients is associated with high in-hospital
and long-term mortality, particularly in patients with Killip class 3-4.
TCT-410
Impact of Age for Treatment of Acute Coronary Syndromes in Elderly Patients
Harald Rittger1, Steffen Schnupp2, Anil Sinha2, Johannes Brachmann2, Johannes
Rieber3
1Med. Klinik II, Universtitätsklinik Erlangen, Erlangen, Germany; 2Klinikum
Coburg, Coburg, Germany; 3Klinikum Bogenhausen, Muenchen, Germany
Background: The purpose of this survey was 1. to determine the management
strategies of elderly patients presenting with acute coronary syndrome (ACS) in a
community hospital, 2. to highlight the reasons for decision making when determining
therapeutic strategies and 3. to investigate the outcome in either interventionally or
conservatively treated patients in a consecutive series of elderly patients above 75 years
of age, presenting to our hospital with ACS.
Methods: This is a retrospective analysis of 1001 consecutive elderly patients (>75
ys.) presenting with ACS. Patients were identified on the basis of their final discharge
diagnosis. The treatment decision was left to the discretion of the physician Baseline
data, past medical history, cardiac and non-cardiac concomitant diseases and adverse
outcomes as well as the reasons for decision making when determining therapeutic
strategies were evaluated.
Results: 776 (77.5%) patients were treated invasively and 225 (22.5%) conservatively.
Logistic regression analysis revealed, that patients with advanced age, Killip class >
II, pre-existing CAD prior stroke, pre-existing renal failure, obesity, NSTEMI, prior
ACS, and presence of supraventricular arrhythmias were significantly more likely to
undergo conservative treatment. In-hospital mortality was significantly higher in
conservatively treated patients (p<0.001). Complication rates were not significantly
different between both groups.
Conclusion: In our retrospective analysis, we were able to identify a number of
parameters, that were independently associated with the choice for a conservative
treatment in the elderly. The selection is mainly driven by the age of the patient and
the concern of complications. However, a more aggressive interventional treatment
strategy in elderly patients was associated with a significantly better outcome.
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